decisionhealth Newsletters, Coder Pink Sheets - 2008 Issue 1 (January)
2008 vs. 2007 Medicare Fees for Drugs Billed Most Often by Orthopedists
Subscribe or sign in to view the full article.
Article Overview
This article presents a comparative table for orthopedic practice drugs, focusing on Medicare billing volume, fee changes between late 2007 and early 2008, denial rates, and whether each drug is available through CAP. It is useful for orthopedists, practice managers, and coding/billing staff who want to evaluate utilization patterns and assess how Medicare payment changes may affect their practice. The article is centered on a data-driven list rather than narrative guidance, making it a quick reference for identifying commonly billed injectable and related drugs in orthopedic settings.
Why This Topic Matters
Orthopedic practices often rely on high-volume drug administration, so shifts in Medicare fees and denial rates can affect reimbursement and purchasing decisions. The table helps practices compare their own utilization against national patterns and understand which drugs are included in CAP.
What You Will Learn
- How the article compares Medicare drug fee data across two time periods
- What kinds of utilization and denial information are included for orthopedic practice drugs
- How the table is organized to support CAP-related practice review
- Which broad categories of drugs are represented in the orthopedic setting
Who Should Read This
- Orthopedic physicians
- Practice managers
- Medical coders
- Billing staff
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com